Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters
Database
Language
Document Type
Year range
1.
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
Sherman, Amy C; Desjardins, Michaël; Cheng, Chi An; Bausk, Bruce; Izaguirre, Natalie; Zhou, Guohai; Krauss, Jonathan; Tolan, Nicole; Walt, David R; Soiffer, Robert; Ho, Vincent T; Issa, Nicolas C; Baden, Lindsey R.
Clin Infect Dis ; 75(1): e920-e923, 2022 Aug 24.
Article in English | MEDLINE | ID: covidwho-2008524

ABSTRACT

The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine-induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort.


Subject(s)
COVID-19 , Hematopoietic Stem Cell Transplantation , mRNA Vaccines , COVID-19/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , SARS-CoV-2 , Vaccines , Vaccines, Synthetic , mRNA Vaccines/adverse effects
2.
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies.
Crombie, Jennifer L; Sherman, Amy C; Cheng, Chi-An; Ryan, Christine E; Zon, Rebecca; Desjardins, Michaël; Baker, Peter; McDonough, Mikaela; Izaguirre, Natalie; Bausk, Bruce; Krauss, Jonathan; Gilboa, Tal; Senussi, Yasmeen; Walt, David R; Davids, Matthew S; Brown, Jennifer R; Armand, Philippe; Baden, Lindsey R; Issa, Nicolas.
Blood Adv ; 5(16): 3062-3065, 2021 08 24.
Article in English | MEDLINE | ID: covidwho-1398833

Subject(s)
COVID-19 , Neoplasms , COVID-19 Vaccines , Humans , RNA, Messenger , SARS-CoV-2
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL